Drug & medication recalls Moderate risk

Conzerol zero molluscum contagiosum recalled over manufacturing violations

Recall date
November 9, 2022
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
DISCOVERY PHARMA LLC recalls Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz…
Recall number
D-0261-2023
FDA classification
Class II
Brand / firm
DISCOVERY PHARMA LLC
Sold / distributed
CA, FL, WA

Why it was recalled

CGMP deviations

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 60322 00180 8, Manufactured by: Dr. Retter EC Warszawska 17, 05-075 Warszawa Poland

Get recall alerts

Free email alert whenever DISCOVERY PHARMA LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: DISCOVERY PHARMA LLC